Status:
RECRUITING
Bilateral Ultrasound Guided Intramuscular Quadratus Lumborum Plane Block Versus Bilateral Lateral Quadratus Lumborum Plane Block in Controlling Postoperative Pain in Cancer Patients Undergoing Open Nephrectomy
Lead Sponsor:
National Cancer Institute, Egypt
Conditions:
Bilateral
Ultrasound
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This study aims to evaluate the efficacy of bilateral ultrasound-guided intramuscular quadratus lumborum plane block (QL4) versus bilateral lateral quadratus lumborum plane block (QL1) in controlling ...
Detailed Description
Post-surgical somatic pain is very distressing to patients, which may lead to significant complications. Practitioners initially used these as ilioinguinal, iliohypogastric, rectus sheath blocks, and...
Eligibility Criteria
Inclusion
- Age from 18 to 65 years.
- Both sexes.
- American Society of Anesthesiology (ASA) physical status II-III.
- Body mass index (BMI): (20- 40) kg/m2.
- Type of surgery: midline incision for unilateral open nephrectomy.
Exclusion
- Patient refusal.
- Age \<18 years or \>65 years
- BMI \<20 kg/m2 and \> 40 kg/m2
- Known sensitivity or contraindication to drugs used in the study
- Contraindication to regional anesthesia, e.g. local infection at the introduction site, pre-existing peripheral neuropathies and coagulopathy.
- Physical status ASA IV
- Patients on chronic analgesic therapy (daily morphine ≥30 mg or equivalent dose of other opioids or tramadol or any medication for neuropathic pain)
- Patients with a history of drug abuse
- Patients with neuropsychiatric diseases; patients with a history of chronic pain syndromes that may enhance sensitivity to pain, for example, fibromyalgia
- All patients who are going to have severe intra- or post-operative bleeding or will require postoperative mechanical ventilation are also excluded from the study.
Key Trial Info
Start Date :
December 10 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 6 2025
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06889987
Start Date
December 10 2024
End Date
December 6 2025
Last Update
March 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Institute
Cairo, Egypt, 11796